Tau is hyperphosphorylated at multiple sites in mouse brain in vivo after streptozotocin-induced insulin deficiency

Diabetes

Volumn 55, Issue 12, 2006, Pages 3320-3325

  Clodfelder Miller, Buffie J ^a   Zmijewska, Anna A ^a   Johnson, Gail V W ^a   Jope, Richard S ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN; PHOSPHOPROTEIN PHOSPHATASE 2A; PROTEIN ANTIBODY; STREPTOZOCIN; TAU PROTEIN; TAU PROTEIN ANTIBODY;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN; BRAIN CORTEX; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; ENZYME ACTIVITY; HIPPOCAMPUS; IN VIVO STUDY; INSULIN DEFICIENCY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION;

ALZHEIMER DISEASE; ANIMALS; BRAIN; CEREBRAL CORTEX; DIABETES MELLITUS, EXPERIMENTAL; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; INSULIN; MALE; MICE; MICE, INBRED C57BL; PHOSPHORYLATION; TAU PROTEINS;

EID: 33845515523     PISSN: 00121797     EISSN: 00121797     Source Type: Journal    
DOI: 10.2337/db06-0485     Document Type: Article

References (33)

1. Schulingkamp R, Pagano D, Hung D, Raffa R: Insulin receptors and insulin action in the brain: review and clinical implications. Neurosci Biobehavioral Rev 24:855-872, 2000
2. Kyriaki G: Brain insulin: regulation, mechanisms of action and functions. Cell Mol Neurobiol 23:1-25, 2003
3. King H, Aubert RE, Herman WH: Global burden of diabetes, 1995-2025: prevalence, numerical estimates and projections. Diabetes Care 21:1414-1431, 1998
4. Gispen WH, Biessels GJ: Cognition and synaptic plasticity in diabetes mellitus. Trends Neurosci 23:542-549, 2000
5. Plum L, Schubert M, Bruning J: The role of insulin receptor signaling in the brain. Trends Endo Metab 16:59-65, 2005
6. Craft S, Peskind E, Schwartz MW, Schellenberg GD, Raskind M, Porte D Jr: Cerebrospinal fluid and plasma insulin levels in Alzheimer's disease: relationship to severity of dementia and apolipoprotein E genotype. Neurology 50:164-168, 1998
7. Hoyer S: Is sporadic Alzheimer disease the brain type of non-insulin dependent diabetes mellitus? A challenging hypothesis. J Neural Transm 105:415-422, 1998
8. Ott A, Stolk RP, van Harskamp F, Pols A, Hofman A, Breteler M: Diabetes mellitus and the risk of dementia: the Rotterdam Study. Neurology 53:1937-1942, 1999
9. Gasparini L, Netzer WJ, Greengard P, Xu H: Does insulin dysfunction play a role in Alzheimer's disease? Trends Pharmacol Sci 23:288-293, 2002
10. Beeri M, Goldbourt U, Silverman J, Noy S, Schmeidler J, Ravona-Springer R, Sverdlick A, Davidson M: Diabetes mellitus in midlife and the risk of dementia three decades later. Neurology 63:1902-1907, 2004
11. Janson J, Laedtke T, Parisi JE, O'Brien P, Petersen RC, Butler PC: Increased risk of type 2 diabetes in Alzheimer disease. Diabetes 53:474-481, 2004
12. Johnson G, Stoothoff W: Tau phosphorylation in neuronal cell function and dysfunction. J Cell Sci 117:5721-5729, 2004
13. Avila J, Diaz-Nido J: Tangling with hypothermia. Nat Med 10:460-461, 2004
14. Hong M, Lee VMY: Insulin and insulin-like growth factor-1 regulate tau phosphorylation in cultured human neurons. J Biol Chem 272:19547-19553, 1997
15. Bradford M: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248-254, 1976
16. Planel E, Miyasaka T, Launery T, Chui DH, Tanemura K, Sato S, Murayama O, Ishiguro K, Tatebayashi Y, Takashima A: Alterations in glucose metabolism induce hypothermia leading to tau hyperphosphorylation through differential inhibition of kinase and phosphatase activities: implications for Alzheimer's disease. J Neurosci 24:2401-2411, 2004
17. Clodfelder-Miller B, De Sarno P, Zmijewska A, Song L, Jope R: Physiological and pathological changes in glucose regulate brain Akt and glycogen synthase kinase-3. J Biol Chem 280:39723-39731, 2005
18. Liu F, Grunke-Iqbal I, Iqbal K, Gong CX: Contribution of protein phosphatases PP1, PP2A, PP2B and PP5 to the regulation of tau phosphorylation. Eur J Neur 22:1942-1950, 2005
19. Schubert M, Gautam D, Surjo D, Ueki K, Baudler S, Schubert D, Kondo T, Alber J, Galldiks N, Kustermann E, Arndt S, Jacobs A, Krone W, Kahn C, Bruning J: Role for neuronal insulin resistance in neurodegenerative diseases. Proc Natl Acad Sci U S A 101:3100-3105, 2004
20. Schechter R, Beju D, Miller K: The effect of insulin deficiency on tau and neurofilament in the insulin knockout mouse. Biochem Biophys Res Commun 334:979-986, 2005
21. Schubert M, Brazil D, Burks D, Kushner J, Ye J, Flint C, Farhand-Fallah J, Dikkes P, Warot X, Rio C, Corfas G, White M: Insulin receptor substrate-2 deficiency impairs brain growth and promotes tau phosphorylation. J Neurosci 23:7084-7092, 2003
22. Trojanowski J, Lee VM: Phosphorylation of paired helical filament tau in Alzheimer's disease neurofibrillary lesions: focusing on phosphatases. FASEB J 15:1570-1576, 1995
23. Lim J, Lu K: Pinning down phosphorylated tau and tauopathies. Biochim Biophys Acta 1739:311-322, 2005
24. Goedert M, Cohen E, Jakes R, Cohen P: p42 MAP kinase phosphorylation sites in microtubule-associated protein tau are dephosphorylated by protein phosphatase 2A1: implications for Alzheimer's disease. FEBS Lett 312:95-99, 1992
25. Merrick S, Trojanowski J, Lee V: Selective destruction of stable microtubules and axons by inhibitors of protein serine/threonine phosphatases in cultured human neurons. J Neurosci 15:5726-5737, 1997
26. Sontag E, Nunbhakdi-Craig V, Lee G, Brandt R, Kamibayashi C, Kuret J, White CL III, Mumby MC, Bloom GS: Molecular interactions among protein phosphatase 2A, tau, and microtubules: implications for the regulation of tau phosphorylation and the development of tauopathies. J Biol Chem 274:25490-25498, 1999
27. Bennecib M, Gong C, Grundke-Iqbal I, Iqbal K: Role of protein phosphatase-2A and -1 in the regulation of GSK-3, cdk5 and cdc2 and the phosphorylation of tau in rate forebrain. FEBS Lett 485:87-93, 2000
28. Gong CX, Singh T, Wang JZ, Zaidi T, Grundke-Iqbal I, Iqbal K: Phosphoprotein phosphatase activities in Alzheimer disease brain. J Neurochem 61:921-927, 1993
29. Matsuo E, Shin R, Billingsley M, Van deVoorde A, O'Connor M, Trojanowski JQ, Lee VM: Biopsy-derived adult human brain tau is phosphorylated at many of the same sites as Alzheimer's disease paired helical filament tau. Neuron 4:989-1002, 1994
30. Vogelsberg-Ragaglia V, Schuck T, Trojanowski J, Lee V: PP2A mRNA expression is quantitatively decreased in Alzheimer's disease hippocampus. Exp Neurol 168:402-412, 2001
31. Sontag E, Luangpirom A, Hladik C, Mudrak I, Ogris E, Speciale S, White CL III: Altered expression levels of the protein phosphatase 2A ABαC enzyme are associated with Alzheimer disease pathology. J Neuropathol Exp Neurol 63:287-301, 2004
32. Sontag E, Hladik C, Montgomery L, Luangpirom A, Mudrak I, Ogris E, White CL III: Downregulation of protein phosphatase 2A carboxyl methylation and methyltransferase may contribute to Alzheimer disease pathogenesis. J Neuropathol Exp Neurol 63:1080-1091, 2004
33. Gong CX, Shaikh S, Wang JZ, Zaidi T, Grundke-Iqbal I, Iqbal K: Phosphatase activity toward abnormally phosphorylated tau: decrease in Alzheimer disease brain. J Neurochem 65:732-738, 1995